Informações:
Falhas:
ID
39014
Descrição
Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01889095
Link
https://clinicaltrials.gov/show/NCT01889095
Palavras-chave
Versões (1)
- 20/11/2019 20/11/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
20 de novembro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Type 2 NCT01889095
Eligibility Diabetes Type 2 NCT01889095
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Type 2 NCT01889095
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
diabetes type 2
boolean
C0011860 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c 8% or higher
boolean
C0474680 (UMLS CUI [1])
Age
Item
age 25 to 65
boolean
C0001779 (UMLS CUI [1])
Insulin Sensitivity altered | Major surgery | Communicable Disease | Kidney Failure | Glomerular Filtration Rate
Item
alteration in insulin sensitivity such as major surgery, infection, renal failure (glomerular filtration rate < 50),
boolean
C0920563 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0679637 (UMLS CUI [2])
C0009450 (UMLS CUI [3])
C0035078 (UMLS CUI [4])
C0017654 (UMLS CUI [5])
C0392747 (UMLS CUI [1,2])
C0679637 (UMLS CUI [2])
C0009450 (UMLS CUI [3])
C0035078 (UMLS CUI [4])
C0017654 (UMLS CUI [5])
Glucocorticoid therapy
Item
glucocorticoid treatment,
boolean
C0744425 (UMLS CUI [1])
Hypoglycaemic episode Serious Recent | Assistance Required
Item
recent (within 2 weeks) serious hypoglycemic episode (requires assistance of another),
boolean
C0745153 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C1269765 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C1269765 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
Study Subject Participation Status
Item
simultaneous participating in another clinical study,
boolean
C2348568 (UMLS CUI [1])
Insulin use
Item
using any type of insulin,
boolean
C0240016 (UMLS CUI [1])
Visual Impairment | Hearing impairment
Item
sight or hearing impaired,
boolean
C3665347 (UMLS CUI [1])
C1384666 (UMLS CUI [2])
C1384666 (UMLS CUI [2])
Proliferative retinopathy Treatment required for | Disorder of macula of retina Treatment required for
Item
active proliferative retinopathy or maculopathy require treatment within 6 months prior to screening,
boolean
C0339467 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C0730362 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
C0332121 (UMLS CUI [1,2])
C0730362 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
Breast Feeding
Item
breast feeding,
boolean
C0006147 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy intended
Item
pregnancy or nursing of the intention of becoming pregnant or
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])
Contraceptive methods Absent
Item
not using adequate contraceptive measures.
boolean
C0700589 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])